Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GALM antisense RNA 1 (GALM-AS1)
- Target
- GALM-AS1
- Molecular classification
- Other (Antisense long non-coding RNA, lncRNA)
01
Overview
GALM antisense RNA 1 (GALM-AS1) is an antisense long non-coding RNA transcribed from the opposite strand of the GALM gene. Antisense lncRNAs as a class are known to regulate expression of their corresponding sense gene through diverse mechanisms, including chromatin modification, transcriptional regulation, and modulation of mRNA stability, but there are no specific reports detailing the function, disease association, drug interactions, or biomarker use of GALM-AS1. The gene is not considered a canonical therapeutic target (such as a receptor, enzyme, or transporter) and no direct biological or pathophysiological function has been established for GALM-AS1 itself.
- Other names
- GALM-AS1antisense lncRNA to GALM
02
Biological functions
Regulation of gene expression (potential)Epigenetic modulation (inferred from antisense lncRNA literature)
03
Disease associations
Unknown (GALM-AS1 specifically not reported in disease roles; general class may be involved in cancer and gene regulation)
Beyond the preview
Go deeper on GALM antisense RNA 1 (GALM-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GALM antisense RNA 1 (GALM-AS1).